Status:
UNKNOWN
Bleb Vascularity Change After Subconjunctival Injection Bevacizumab
Lead Sponsor:
Capital Medical University
Conditions:
Bleb Vascularity
Conjunctival Scarring
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
The occurrence of conjunctival scarring finally leads to the obstruction of the fistula tract created by the filtering surgery. Vascular endothelial growth factor is thought to be a key role in the fo...
Eligibility Criteria
Inclusion
- Glaucoma patients after trabeculectomy whose bleb is hyperaemia
Exclusion
- Affected eye has normal IOP
- Not allergic with Avastin
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2009
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00815594
Start Date
December 1 2008
End Date
May 1 2009
Last Update
December 30 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tongren hospital
Beijing, Beijing Municipality, China, 100730